71 Results

People

  1. Lendvai
    Lendvai
  2. Giralt
    Giralt
  3. Hassoun
    Hassoun
  4. Landau
    Landau
  5. Lesokhin
    Lesokhin
  6. Landgren
    Landgren
  7. Chung
    Chung
  8. Devlin
    Devlin
  9. Koehne
    Koehne
  10. Korde
    Korde

Groups

  1. Center for Hematologic Malignancies (71)
  2. Department of Medicine (71)
  3. Hematologic Malignancies, Division of (71)
  4. Myeloma (71)
  5. Survivorship Research (52)
  6. Hematologic Malignancies Research (51)
  7. Bone Marrow Transplant (49)
  8. Epidemiology and Biostatistics (37)
  9. Biostatistics Service (34)
  10. Sloan Kettering Institute Postdocs (13)
  1. "Meeting abstract"
  2. "Nikoletta Lendvai"
Formats
  1. Meeting Abstract (71)
Groups
  1. Center for Hematologic Malignancies (71)
  2. Department of Medicine (71)
  3. Hematologic Malignancies, Division of (71)
  4. Myeloma (71)
  5. Survivorship Research (52)
  6. Hematologic Malignancies Research (51)

More Groups

People
  1. Nikoletta Lendvai (71)
  2. Alexander Lesokhin (47)
  3. Hani Hassoun (47)
  4. Heather Landau (47)
  5. Sergio Giralt (47)
  6. David Chung (41)

More People

Years
  1. 2020 (1)
  2. 2019 (4)
  3. 2018 (8)
  4. 2017 (8)
  5. 2016 (9)
  6. 2015 (12)

More Years

Publications
  1. Blood (43)
  2. Biology of Blood and Marrow Transplantation (10)
  3. Journal of Clinical Oncology (6)
  4. Haematologica (5)
  5. Clinical Lymphoma, Myeloma and Leukemia (4)
  6. Bone Marrow Transplantation (2)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. Elsevier Inc. (14)
  3. American Society of Clinical Oncology (6)
  4. Ferrata Storti Foundation (5)
  5. Nature Publishing Group (2)
  6. American Association for Cancer Research (1)

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of patient activity bioprofiles with Hrqol and clinical responses: A prospective novel trial using mobile wearables in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Tavitian, E.; Derkach, A.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multicenter phase II single arm trial of isatuximab in patients with high risk smoldering multiple myeloma (HRSMM)
    Meeting Abstract

    Manasanch, E. E.; Jagannath, S.; Lee, H. C.; Patel, K. K.; Graham, C.; Kaufman, G. P.; Thomas, S. K.; Iyer, S.; Mailankody, S.; Korde, N.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence
    Meeting Abstract

    Yellapantula, V. D.; Rustad, E. H.; Glozdik, D.; Gundem, G.; Fan, J.; Medina, J.; Patel, A.; Patel, M.; Hultcrantz, M.; Peled, J. U.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy
    Meeting Abstract

    Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save